<?xml version="1.0" encoding="utf-8"?>
<style xmlns="http://purl.org/net/xbiblio/csl" version="1.0" default-locale="en-US">
  <!-- Mary Ann Liebert, Inc. (MAL), generated from "mal" metadata at https://github.com/citation-style-language/journals -->
  <info>
    <title>Diabetes Technology and Therapeutics</title>
	  <title-short>DTT</title-short>
    <id>http://www.zotero.org/styles/diabetes-technology-and-therapeutics</id>
    <link href="http://www.zotero.org/styles/diabetes-technology-and-therapeutics" rel="self"/>
    <link href="http://www.zotero.org/styles/mary-ann-liebert-vancouver" rel="independent-parent"/>
    <link href="https://home.liebertpub.com/authors/writing-guidelines/151" rel="documentation"/>
    <category citation-format="numeric"/>
    <category field="medicine"/>
    <issn>1520-9156</issn>
    <eissn>1557-8593</eissn>
    <updated>2022-03-05T12:00:00+00:00</updated>
    <rights license="http://creativecommons.org/licenses/by-sa/3.0/">This work is licensed under a Creative Commons Attribution-ShareAlike 3.0 License</rights>
  </info>
</style>
